Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOP Pain: Oxycodone in Cancer Pain
NCT03176121Phase 4Completed
- Sponsor
- Mundipharma
- Start
- Oct 2016
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of oxycodone in cancer pain, sponsored by Mundipharma. Started Oct 2016; status: completed.
02
Drugs
oxycodone
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT03176121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03176121.